Are you the publisher? Claim or contact us about this channel


Embed this content in your HTML

Search

Report adult content:

click to rate:

Account: (login)

More Channels


Showcase


Channel Catalog


Channel Description:

Visit One News Page for Australia news from around the world, aggregated from leading sources including newswires, newspapers and broadcast media. Search millions of archived news headlines. This feed provides the Australia news headlines.

older | 1 | .... | 1400 | 1401 | (Page 1402) | 1403 | 1404 | .... | 1460 | newer

    0 0

    Dublin, Nov. 16, 2018 (GLOBE NEWSWIRE) -- The "Power Rental Market by Fuel (Diesel & Gas), Power Rating, Equipment, End Users (Utilities, Oil & Gas, Events, Construction, Mining, Manufacturing, Shipping, Data Center), Application, Region - Global Forecasts to 2023" report has been added to *ResearchAndMarkets.com's* offering.The global power rental market is projected to reach a size of USD 21.2 billion by 2023, at a CAGR of 7.89%, from an estimated USD 14.5 billion in 2018. This growth can be attributed to the limited access to electricity in rural areas and increase in power loss due to aging infrastructure.

    *By end-user, the utilities segment is expected to grow at the fastest rate during the forecast period*

    The report segments the power rental market, by end-user, into utilities, oil & gas, minning, manufacturing, construction, events, shipping, and data center. Local grids lack reliable supply, mainly due to poor or lack of transmission network in regions such as Africa, Asia Pacific, and in developing countries.

    Unreliable supply from a local grid or limited access to the main transmission network may prohibit the delivery of electricity required to sustain production and operations. In such cases, there will be a high demand for generators, as users avoid traditional power grids to limit their use of the grid. Hence, there is continuous demand for power rental from power plants in order to ensure continued power supply. Utility companies use rental generators mainly during the peak demand period.

    *By application, the standby power segment is expected to grow at the fastest rate during the forecast period*

    A standby generator is an electrical back-up system that operates within seconds of a power outage. The transfer switch senses the loss of power and accordingly starts or shuts off the generator. Most units run on diesel, natural gas, or liquid propane gas. These generators are used in hospitals, office buildings, and schools, among others.
    Diesel generator accounts for the largest market size during the forecast period.

    Diesel generators are being used for standby, peak shaving, and continuous power generation purposes for decades. The diesel generators have long running life, easy fuel availability, and quick response. These are the factors that boost the growth of the diesel generator market worldwide.

    The advantages of using a diesel generator is its continuous stream of voltage power, without peaks and dips of other devices, thus, helping to regulate fluctuations. Diesel generators find applications mainly in commercial and various manufacturing facilities and are also available in portable forms, which are primarily used by residential customers. These were the major reasons behind the diesel generator market holding the maximum share in 2017.

    *North America is expected to account for the largest market size during the forecast period*

    In this report, the power rental market has been analyzed with respect to 6 regions, namely, North America, Europe, South America, Asia Pacific, Africa, and the Middle East. The market in North America is estimated to be the largest during the forecast period. Increasing power demand and aging infrastructure are some of the key factors responsible for the growth of the power rental market. According to National Energy Board Canada, total export of 72.1 tWh (tera watt hours) of electricity was done to US in 2017.

    The US government have been trying to reduce the electricity import in the country over a decade. But the increasing oil prices have impacted the growth, creating the power deficit. The deficit provides market opportunity for power rental solution. Such factors would boost the power rental market in the region during the forecast period.

    The major players in the global power rental market are Aggreko (UK), Caterpillar (US), United Rental (US), Atlas Copco (Sweden), Cummins (US), Ashtead Group (UK), SEL (US), APR Energy (US), Kohler (US), Rental Solutions & Services (UAE), HERC (US), Generac Power Systems (US), Wacker Neuson (Germany), and Wartsila Corporation (Finalnc). Aggreko, United Rental, Caterpillar are the prominent player of the power rental market. The players are adopting inorganic growth strategies for the expansion of their presence in various regions

    *Market Developments*· United Rentals, Inc. acquired NES Rentals Holdings II, Inc. The acquisition is expected to increase the company's presence in the East Coast, Gulf states, and the Midwest of the US.
    · Aggreko received a contract to provide around 60 generators supplying more than 10 MVA (mega volt ampere) of energy, distributed through more than 240 panel and 26 km of cable for Glasgow 2018 European Championship
    · Caterpillar Inc. and Ritchie Bros. formed a partnership under which Ritchie Bros. will become Caterpillar's preferred global partner for onsite and online auctions for used Caterpillar equipment. The partnership is expected to strengthen Ritchie Bros. relationship with independent Caterpillar dealers around the world by providing them enhanced and continued access to a global auction marketplace to sell their used equipment.*Key Topics Covered**1 Introduction*
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Markets Covered
    1.4 Years Considered for the Study
    1.5 Currency
    1.6 Limitations
    1.7 Stakeholders

    *2 Research Methodology*
    2.1 Introduction
    2.1.1 Secondary Data
    2.1.1.1 Key Data From Secondary Sources
    2.1.2 Primary Data
    2.1.2.1 Key Data From Primary Sources
    2.1.2.2 Key Industry Insights
    2.1.2.3 Breakdown of Primaries
    2.2 Market Size Estimation
    2.2.1 Bottom-Up Approach
    2.2.2 Top-Down Approach
    2.3 Market Breakdown & Data Triangulation
    2.4 Research Assumptions & Limitations
    2.4.1 Assumptions
    2.4.2 Limitations

    *3 Executive Summary*

    *4 Premium Insights*
    4.1 Power Rental Market, By Country
    4.2 Power Rental Market, By End-User
    4.3 Power Rental Market, By Application
    4.4 Power Rental Market, By Power Rating
    4.5 Power Rental Market, By Fuel Type
    4.6 Power Rental Market, By Equipment
    4.7 North American Power Rental Market

    *5 Market Overview*
    5.1 Introduction
    5.2 Market Dynamics
    5.2.1 Drivers
    5.2.1.1 Limited Access to Electricity in Rural Areas
    5.2.1.2 Increase in Power Loss Due to Aging Infrastructure.
    5.2.1.3 New Customized Compressed Air Rental Solution
    5.2.2 Restraints
    5.2.2.1 Slowdown in Global Economies
    5.2.2.2 Uncertainty in Raw Material Prices
    5.2.3 Opportunities
    5.2.3.1 Obsolete Permanent Power Plants
    5.2.3.2 Deccarbonization & Decentralization of Energy Mix
    5.2.3.3 Next Generation Air Compressors
    5.2.4 Challenges
    5.2.4.1 Stringent Emission Regulations Effecting Diesel Fuel Type Generator

    *6 Power Rental Market, By End-User*
    6.1 Introduction
    6.2 Utilities
    6.2.1 Africa is Expected to Hold the Largest Market Share
    6.3 Oil & Gas
    6.3.1 North America is Expected to Hold the Largest Market Share
    6.4 Events
    6.4.1 Middle East is Expected to Be the Fastest Growing Market for Event Segment
    6.5 Construction
    6.5.1 Asia Pacific is Expected to Hold the Largest Market Share of Construction Segment
    6.6 Mining
    6.6.1 North America is Expected to Grow in Mining Segment Driving Demand for Power Rental Solution
    6.7 Manufacturing
    6.7.1 Increasing Investment in Manufacturing Sector in Asia Pacific is Driving the Power Rental Market in Manufacturing Segment
    6.8 Shipping
    6.8.1 South America is Expected to Grow at the Fastest Rate in the Shipping Segment
    6.9 Data Center
    6.9.1 North America is Expected to Create Demand in Data Center Segment
    6.10 Others

    *7 Power Rental Market, By Application*
    7.1 Introduction
    7.2 Peak Shaving
    7.2.1 The Aging T&D Infrastructure is Expected to Drive Peak Shaving Market
    7.3 Standby Power
    7.3.1 Increasing Requirement of Continuous Power Flow to Maintain Efficency is Driving the Standby Power Market
    7.4 Base Load/Continuous Power
    7.4.1 Increasing Demand From Utilities and Mining End-User is Driving Base Load/Continuous Power Market

    *8 Power Rental Market, By Power Rating*
    8.1 Introduction
    8.2 Up to 50 Kw Power Rating
    8.2.1 Increasing Requirement in Construction Industry is Driving the Market for Up to 50 Kw Segment
    8.3 51 -500 Kw Power Rating
    8.3.1 North America is Expected to Be the Largest Market in 51 - 500 Kw Segment
    8.4 501 -2,500 Kw Power Rating
    8.4.1 Oil & Gas and Utilities are Driving the Market for 501-2,500 Kw Segment

    *9 Power Rental Market, By Fuel Type*
    9.1 Introduction
    9.2 Diesel Generators
    9.2.1 Technical Efficency and Easy Availability of Diesel are Driving the Diesel Generator Market
    9.3 Gas Generators
    9.3.1 Stringent Emission Norms are Creating Market for Gas Generator
    9.4 Others

    *10 Power Rental Market, By Equipment*
    10.1 Introduction
    10.2 Generator
    10.2.1 Increasing Demand for Continuous Power Supply is Creating Opportunity for Generators
    10.3 Transformer
    10.3.1 Increasing Demand for Temporary Power Plant is Driving Transformer Market
    10.4 Load Bank
    10.4.1 Manufacturing and Construction Industries are Driving the Load Bank Market
    10.5 Others

    *11 Power Rental Market, By Region*
    11.1 Introduction
    11.2 Asia Pacific
    11.2.1 By End-User
    11.2.2 By Fuel Type
    11.2.3 By Application
    11.2.4 By Equipment
    11.2.5 By Country
    11.2.5.1 China
    11.2.5.1.1 Growing Investment in Mining Activities is Expected to Create Opportunity for Power Rental Market
    11.2.5.2 India
    11.2.5.2.1 Increasing Investment in Manufacturing and Construction Sector is Expected to Drive the Power Rental Market in India
    11.2.5.3 Australia
    11.2.5.3.1 Aging Power Infrastructure and Growing Power Requirement are Driving the Power Rental Market in the Region.
    11.2.5.4 Japan
    11.2.5.4.1 Increasing Investment in the Construction Industry is Expected to Drive the Power Rental Market in Japan
    11.2.5.5 Singapore
    11.2.5.5.1 Manufacturing and Construction Industries are Expected to Drive the Power Rental Market in Singapore
    11.2.5.6 Indonesia
    11.2.5.6.1 Utilities and Manufacturing Sectors are Driving the Power Rental Market in Indonesia
    11.2.5.7 Bangladesh
    11.2.5.7.1 Poor T&D Infrastructure is Driving the Market in Bangladesh
    11.2.5.8 The Rest of Asia Pacific
    11.3 North America
    11.3.1 By End-User
    11.3.2 By Fuel Type
    11.3.3 By Application
    11.3.4 By Equipment
    11.3.5 By Country
    11.3.5.1 Us
    11.3.5.1.1 Aging T&D Infrastructure and Increasing Power Requirement are Driving the Power Rental Market in the Region.
    11.3.5.2 Canada
    11.3.5.2.1 Utilities and Oil & Gas Industries are Expected to Drive the Power Rental Market in Canada
    11.3.5.3 Mexico
    11.3.5.3.1 Growing Industrialization and Increasing Power Requirement is Driving the Power Rental Market in Mexico
    11.4 South America
    11.4.1 By End-User
    11.4.2 By Fuel Type
    11.4.3 By Application
    11.4.4 By Equipment
    11.4.5 By Country
    11.4.5.1 Brazil
    11.4.5.1.1 Manufacturing Industry is Expected to Drive the Requirement for Power Rental Solution in Brazil
    11.4.5.2 Argentina
    11.4.5.2.1 Lack of Centralized Grid and Poor T&D Infrastructure are Driving the Power Rental Market in the Region
    11.4.5.3 Chile
    11.4.5.3.1 Utilities are the Largest End-User for Power Rental Market in Chile
    11.4.5.4 The Rest of South America
    11.5 Europe
    11.5.1 By End-User
    11.5.2 By Fuel Type
    11.5.3 By Application
    11.5.4 By Equipment
    11.5.5 By Country
    11.5.5.1 UK
    11.5.5.1.1 Oil & Gas and Construction Industries are Expected to Drive the Power Rental Market in the Region
    11.5.5.2 Germany
    11.5.5.2.1 Increasing Investment in Construction Industry is Expected to Drive the Power Rental Market in the Country.
    11.5.5.3 Russia
    11.5.5.3.1 Oil & Gas End-User Segment is Expected to Hold the Largest Share for Power Rental Market in Russia
    11.5.5.4 Italy
    11.5.5.4.1 Increasing Investment in Construction Industry is Expected to Drive the Power Rental Market in Italy
    11.5.5.5 France
    11.5.5.5.1 Aging Power Plants are Driving the Requirement for Power Rental Solution
    11.5.5.6 Turkey
    11.5.5.6.1 Utilities are Expected to Drive Demand for Power Rental Solution in Turkey
    11.5.5.7 Rest of Europe
    11.6 Middle East
    11.6.1 By End-User
    11.6.2 By Fuel Type
    11.6.3 By Application
    11.6.4 By Equipment
    11.6.5 By Country
    11.6.5.1 Saudi Arabia
    11.6.5.1.1 Stable Oil Prices are Expected to Promote Major Oil & Gas Projects, Creating Requirement for Power Rental Solutions
    11.6.5.2 UAE
    11.6.5.2.1 The Growing Power Requirement is Expected to Drive the Power Rental Market
    11.6.5.3 Iran
    11.6.5.3.1 Poor Power Infrastructure is Creating Opportunity for Power Rental Market
    11.6.5.4 Qatar
    11.6.5.4.1 Utilities are Expected to Drive the Power Rental Market in Qatar
    11.6.5.5 OMAN
    11.6.5.5.1 Event Segment is Expected to Be the Fastest Growing End-User Segment for Power Rental Market in OMAN
    11.6.5.6 Rest of the Middle East
    11.7 Africa
    11.7.1 By End User
    11.7.2 By Fuel Type
    11.7.3 By Application
    11.7.4 By Equipment
    11.7.5 By Country
    11.7.5.1 Algeria
    11.7.5.1.1 Utility Segment is Expected to Hold the Largest Share
    11.7.5.2 Egypt
    11.7.5.2.1 Utility is Expected to Be the Fastest Growing Market for Power Rental in Egypt
    11.7.5.3 South Africa
    11.7.5.3.1 Increasing Investment in Mining Activities is Driving the Power Rental Market in the Country
    11.7.5.4 Nigeria
    11.7.5.4.1 Utility Holds the Largest Market Share for Power Rental Market in Nigeria
    11.7.5.5 Libya
    11.7.5.5.1 The Aging Power Infrastructure is Driving the Power Rental Market in Libya
    11.7.5.6 Mozambique
    11.7.5.6.1 Increasing Power Requirement is Driving the Power Rental Market in the Country
    11.7.5.7 The Rest of Africa

    *12 Competitive Landscape*
    12.1 Introduction
    12.2 Ranking of Players, 2017
    12.3 Competitive Scenario
    12.3.1 Competitive Analysis
    12.3.2 Contracts & Agreements
    12.3.3 New Product Developments
    12.3.4 Investments & Expansions
    12.3.5 Mergers & Acquisitions

    *13 Company Profiles*
    13.1 Benchmarking
    13.2 Caterpillar
    13.3 Atlas Copco
    13.4 Cummins
    13.5 United Rentals
    13.6 Ashtead Group
    13.7 Aggreko, PLC
    13.8 APR Energy
    13.9 Bredenoord Exploitatiemij B.V.
    13.10 Kohler Co.
    13.11 Rental Solutions & Services
    13.12 Herc Holdings Inc
    13.13 Generac Power Systems
    13.14 Wacker Neuson SE
    13.15 Wartsila Corporation
    13.16 Speedy Hire PLC
    13.17 Smart Energy Solutions
    13.18 Soenergy International
    13.19 Multiquip Inc.For more information about this report visit https://www.researchandmarkets.com/research/xvwdwb/global_power?w=12

    CONTACT:
    CONTACT: ResearchAndMarkets.com
    Laura Wood, Senior Press Manager
    press@researchandmarkets.com
    For E.S.T Office Hours Call 1-917-300-0470
    For U.S./CAN Toll Free Call 1-800-526-8630
    For GMT Office Hours Call +353-1-416-8900
    Related Topics: Electricity Reported by GlobeNewswire 3 hours ago.

    0 0

    Reported by RIA Nov. 2 hours ago.

    0 0

    *TR-1: S**tandard form for notification of major holdings*

    *NOTIFICATION OF MAJOR HOLDINGS* (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i
     
    *1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached*ii*:* G4S PLC
    *1b. Please indicate if the issuer is a non-UK issuer  *(please mark with an “X” if appropriate)
    Non-UK issuer  
    *2. Reason for the notification *(please mark the appropriate box or boxes with an “X”)
    An acquisition or disposal of voting rights X
    An acquisition or disposal of financial instruments  
    An event changing the breakdown of voting rights  
    Other (please specify)iii:  
    *3. Details of person subject to the notification obligation*iv
    Name BlackRock, Inc.
    City and country of registered office (if applicable) Wilmington, DE, USA
    *4. Full name of shareholder(s)* (if different from 3.)v
    Name  
    City and country of registered office (if applicable)  
    *5. Date on which the threshold was crossed or reached*vi*:* 15/11/2018
    *6. Date on which issuer notified (DD/MM/YYYY):* 16/11/2018
    *7. Total positions of person(s) subject to the notification obligation*
      % of voting rights attached to shares (total of 8. A) % of voting rights through financial instruments
    (total of 8.B 1 + 8.B 2) Total of both in % (8.A + 8.B) Total number of voting rights of issuervii
    Resulting situation on the date on which threshold was crossed or reached 5.00 % 0.58 % 5.59 % 1,551,594,436
    Position of previous notification (if
    applicable) 4.97 % 0.60 % 5.58 %  *8. Notified details of the resulting situation on the date on which the threshold was crossed or reached*viii
    *A: Voting rights attached to shares*
    *Class/type of
    shares*
    ISIN code (if possible) *Number of voting rights*ix *% of voting rights*
    *Direct*
    (Art 9 of Directive 2004/109/EC) (DTR5.1) *Indirect*
    (Art 10 of Directive 2004/109/EC) (DTR5.2.1) *Direct*
    (Art 9 of Directive 2004/109/EC) (DTR5.1) *Indirect*
    (Art 10 of Directive 2004/109/EC) (DTR5.2.1)
    GB00B01FLG62   77,685,325   5.00 %
             
             
    *SUBTOTAL 8. A* 77,685,325 5.00 %
     

     
    *B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))*
    *Type of financial instrument* *Expiration
    date*x *Exercise/
    Conversion Period*xi *Number of voting rights that may be acquired if the instrument is *
    *exercised/converted.* *% of voting rights*
    Securities Lending     8,663,825 0.55 %
             
             
        *SUBTOTAL 8. B 1* 8,663,825 0.55 %
     

     
    *B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))*
    *Type of financial instrument* *Expiration
    date*x *Exercise/
    Conversion Period *xi *Physical or cash *
    *settlement*xii *Number of voting rights * *% of voting rights*
    CFD     Cash 470,251 0.03 %
               
               
        * * *SUBTOTAL 8.B.2* 470,251 0.03 %
     

     

     

    *9. Information in relation to the person subject to the notification obligation *(please mark the
    applicable box with an “X”)
    Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii  
    Full chain of controlled undertakings through which the voting rights and/or the
    financial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary) X
    *Name*xv *% of voting rights if it equals or is higher than the notifiable threshold* *% of voting rights through financial instruments if it equals or is higher than the notifiable threshold* *Total of both if it equals or is higher than the notifiable threshold*
    See Attachment      
    * *
    *10. In case of proxy voting, please identify:*
    Name of the proxy holder  
    The number and % of voting rights held  
    The date until which the voting rights will be held  
     
    *11. Additional information*xvi
     

     

    *Place of completion* 12 Throgmorton Avenue, London, EC2N 2DL, U.K.
    *Date of completion* 16 November, 2018

    *Section 9 Attachment*

    *Name*xv *% of voting rights if it equals or is higher than the notifiable threshold* *% of voting rights through financial instruments if it equals or is higher than the notifiable threshold* *Total of both if it equals or is higher than the notifiable threshold*
    BlackRock, Inc.      
    BlackRock Holdco 2, Inc.      
    BlackRock Financial Management, Inc.      
    BlackRock Holdco 4, LLC      
    BlackRock Holdco 6, LLC      
    BlackRock Delaware Holdings Inc.      
    BlackRock Fund Advisors      
           
    BlackRock, Inc.      
    BlackRock Holdco 2, Inc.      
    BlackRock Financial Management, Inc.      
    BlackRock International Holdings, Inc.      
    BR Jersey International Holdings L.P.      
    BlackRock Holdco 3, LLC      
    BlackRock Cayman 1 LP      
    BlackRock Cayman West Bay Finco Limited      
    BlackRock Cayman West Bay IV Limited      
    BlackRock Group Limited      
    BlackRock Finance Europe Limited      
    BlackRock Advisors (UK) Limited      
           
    BlackRock, Inc.      
    BlackRock Holdco 2, Inc.      
    BlackRock Financial Management, Inc.      
    BlackRock Holdco 4, LLC      
    BlackRock Holdco 6, LLC      
    BlackRock Delaware Holdings Inc.      
    BlackRock Institutional Trust Company, National Association      
           
    BlackRock, Inc.      
    BlackRock Holdco 2, Inc.      
    BlackRock Financial Management, Inc.      
    BlackRock International Holdings, Inc.      
    BR Jersey International Holdings L.P.      
    BlackRock Holdco 3, LLC      
    BlackRock Cayman 1 LP      
    BlackRock Cayman West Bay Finco Limited      
    BlackRock Cayman West Bay IV Limited      
    BlackRock Group Limited      
    BlackRock Finance Europe Limited      
    BlackRock Investment Management (UK) Limited      
           
    BlackRock, Inc.      
    BlackRock Holdco 2, Inc.      
    BlackRock Financial Management, Inc.      
    BlackRock Capital Holdings, Inc.      
    BlackRock Advisors, LLC      
           
    BlackRock, Inc.      
    BlackRock Holdco 2, Inc.      
    BlackRock Financial Management, Inc.      
    BlackRock International Holdings, Inc.      
    BR Jersey International Holdings L.P.      
    BlackRock Holdco 3, LLC      
    BlackRock Cayman 1 LP      
    BlackRock Cayman West Bay Finco Limited      
    BlackRock Cayman West Bay IV Limited      
    BlackRock Group Limited      
    BlackRock International Limited      
           
    BlackRock, Inc.      
    BlackRock Holdco 2, Inc.      
    BlackRock Financial Management, Inc.      
           
    BlackRock, Inc.      
    BlackRock Holdco 2, Inc.      
    BlackRock Financial Management, Inc.      
    BlackRock International Holdings, Inc.      
    BR Jersey International Holdings L.P.      
    BlackRock (Singapore) Holdco Pte. Ltd.      
    BlackRock HK Holdco Limited      
    BlackRock Lux Finco S.a.r.l.      
    BlackRock Trident Holding Company Limited      
    BlackRock Japan Holdings GK      
    BlackRock Japan Co., Ltd.      
           
    BlackRock, Inc.      
    BlackRock Holdco 2, Inc.      
    BlackRock Financial Management, Inc.      
    BlackRock International Holdings, Inc.      
    BR Jersey International Holdings L.P.      
    BlackRock Holdco 3, LLC      
    BlackRock Cayman 1 LP      
    BlackRock Cayman West Bay Finco Limited      
    BlackRock Cayman West Bay IV Limited      
    BlackRock Group Limited      
    BlackRock Finance Europe Limited      
    BlackRock Investment Management (UK) Limited      
    BlackRock Asset Management Deutschland AG      
           
    BlackRock, Inc.      
    BlackRock Holdco 2, Inc.      
    BlackRock Financial Management, Inc.      
    BlackRock International Holdings, Inc.      
    BR Jersey International Holdings L.P.      
    BlackRock Holdco 3, LLC      
    BlackRock Canada Holdings LP      
    BlackRock Canada Holdings ULC      
    BlackRock Asset Management Canada Limited      
           
    BlackRock, Inc.      
    Trident Merger, LLC      
    BlackRock Investment Management, LLC      
           
    BlackRock, Inc.      
    BlackRock Holdco 2, Inc.      
    BlackRock Financial Management, Inc.      
    BlackRock International Holdings, Inc.      
    BR Jersey International Holdings L.P.      
    BlackRock (Singapore) Holdco Pte. Ltd.      
    BlackRock HK Holdco Limited      
    BlackRock Asset Management North Asia Limited      
           
    BlackRock, Inc.      
    BlackRock Holdco 2, Inc.      
    BlackRock Financial Management, Inc.      
    BlackRock International Holdings, Inc.      
    BR Jersey International Holdings L.P.      
    BlackRock Australia Holdco Pty. Ltd.      
    BlackRock Investment Management (Australia) Limited      
           
    BlackRock, Inc.      
    BlackRock Holdco 2, Inc.      
    BlackRock Financial Management, Inc.      
    BlackRock International Holdings, Inc.      
    BR Jersey International Holdings L.P.      
    BlackRock Holdco 3, LLC      
    BlackRock Cayman 1 LP      
    BlackRock Cayman West Bay Finco Limited      
    BlackRock Cayman West Bay IV Limited      
    BlackRock Group Limited      
    BlackRock Finance Europe Limited      
    BlackRock (Netherlands) B.V.      
           
    BlackRock, Inc.      
    BlackRock Holdco 2, Inc.      
    BlackRock Financial Management, Inc.      
    BlackRock International Holdings, Inc.      
    BR Jersey International Holdings L.P.      
    BlackRock (Singapore) Holdco Pte. Ltd.      
    BlackRock (Singapore) Limited      
            Reported by GlobeNewswire 3 hours ago.

    0 0

    Dublin, Nov. 16, 2018 (GLOBE NEWSWIRE) -- The "Oil & Gas Sensors Market by Type (Pressure, Level, Flow,Temperature), Connectivity (Wired, Wireless), Application (Remote Monitoring, Condition Monitoring, Analysis), Sector (Upstream, Midstream, Downstream), and Region - Global Forecast to 2023" report has been added to *ResearchAndMarkets.com's* offering.The oil & gas sensors market is expected to grow from USD 7.4 billion in 2018 to USD 9.4 billion by 2023, at a Compound Annual Growth Rate (CAGR) of 4.8%, from 2018 to 2023.The oil & gas sensors market is driven by various factors, such as increasing adoption of ultrasonic sensors and increasing demand for sensors due to refining capacity additions. However, rising investments in the renewable sector can hinder the growth of the oil & gas sensors market.

    *"Pressure sensors segment is expected to grow at a higher CAGR during the forecast period"*

    Pressure sensors segment is the fastest growing segment in the oil & gas sensors market. This sensor is used to measure the pressure of gases or liquids. They are used to provide accurate and reliable data to detect small changes in the pressure usually in the upstream and midstream sector. Hence, increasing use of pressure sensors for upstream and midstream applications is expected to result in the highest CAGR of pressure sensors segment.

    *"Remote monitoring segment is expected to hold the largest market share during the forecast period"*

    Remote monitoring includes pipeline integrity monitoring, tank level monitoring, equipment-based condition monitoring (CBM), pipeline Pressure Relief Valve monitoring, refineries Pressure Relief Valve monitoring, wellhead automation, and monitoring. Remote monitoring can reduce the maintenance cost in marine environments, which are mostly corrosive and require more maintenance.

    *"Asia Pacific is expected to record the highest growth rate during the forecast period"*

    Asia Pacific is expected to have the highest growth rate during the forecast period because of the increasing energy consumption in the region. The oil demand in Asia Pacific would grow by an average of 2% annually by 2023. This would be driven by the rising consumption of petrochemical materials such as ethane and naphtha. It is projected that Asia Pacific would account for roughly 60% of the global oil product demand growth in the next 5 years.

    The oil & gas sensors market comprises major solution providers, such as Emerson (US), ABB (Switzerland), GE (US), Indutrade (Sweden), BD sensors (Germany), Lord (US), MTS Sensors (US), Bosch (Germany), Rockwell (US), TE Connectivity (Switzerland), Fortive (US), and Siemens (Germany). The study includes an in-depth competitive analysis of these key players in the oil & gas sensors market, with company profiles, recent developments, and key market strategies.*Recent Developments*

    · In May 2018, Siemens introduced a new generation temperature transmitter for various sensor types that provide results in extreme temperatures up to -5 degree Celsius. It uses 4 wire connection for both sensors SITRANS TH420 and TR420 to increase data accuracy and reliability.
    · In March 2018, ABB expanded its operations network with a new collaborative operations center for the oil, gas, and chemical industries in Norway.
    · In May 2017, Emerson introduced a new platform for its Rosemount X-well technology for surface sensing temperature measurement solutions.
    · In May 2016, Fortive (Gems Sensors) launched a new Ultrasonic Level Sensor, XLS-1. The ultrasonic sensing technology enables the level sensor to sense oil, water, and harsh chemicals, while ignoring foam and condensation.

    *Key Questions addressed by the report*

    · The report identifies and addresses key markets for oil & gas sensors, which would help manufacturers review the growth in demand.
    · The report helps system providers understand the pulse of the market and provides insights into drivers, restraints, opportunities, and challenges.
    · The report will help key players understand the strategies of their competitors better and make better strategic decisions.
    · The report addresses the market share analysis of key players in oil & gas sensors market, and with the help of this companies can enhance their revenues in the respective market.
    · The report provides insights about emerging geographies for oil & gas sensors, and the entire market ecosystem can gain competitive advantage from such insights.*Key Topics Covered:**1 Introduction*

    *2 Research Methodology*

    *3 Executive Summary*

    *4 Premium Insights*
    4.1 Oil & Gas Sensors Market, By Country
    4.2 Oil & Gas Sensors Market, By Connectivity
    4.3 Oil & Gas Sensors Market, By Type
    4.4 Oil & Gas Sensors Market, By Application
    4.5 Oil & Gas Sensors Market, By Sector
    4.6 Asia Pacific Oil & Gas Sensors Market

    *5 Market Overview*
    5.1 Introduction
    5.2 Market Dynamics
    5.2.1 Drivers
    5.2.1.1 Increasing Adoption of Ultrasonic Sensors
    5.2.1.2 Increasing Demand for Sensors Due to Refining Capacity Additions
    5.2.1.3 Growing Iot in Oil & Gas Industry
    5.2.2 Restraints
    5.2.2.1 Rising Investment in the Renewable Sector Would Affect the Demand for Sensors
    5.2.3 Opportunities
    5.2.3.1 Increasing Unconventional Drilling Techniques Such as Mpd and Directional Drilling
    5.2.3.2 Growing Offshore Investments
    5.2.4 Challenges
    5.2.4.1 Low Acceptance Level Toward Adopting New Technologies

    *6 Oil & Gas Sensors Market, By Type*
    6.1 Introduction
    6.2 Pressure Sensor
    6.2.1 34
    6.3 Temperature Sensor
    6.4 Level Sensor
    6.5 Flow Sensor
    6.6 Others

    *7 Oil & Gas Sensors Market, By Application*
    7.1 Introduction
    7.2 Remote Monitoring
    7.2.1 Asia Pacific is Projected to Be the Largest Market for Remote Monitoring
    7.3 Condition Monitoring & Maintenance
    7.3.1 North America is Projected to Be the Fastest Growing Market for Condition Monitoring & Maintenance
    7.4 Analysis & Simulation
    7.4.1 North America is Expected to Hold the Largest Market Share

    *8 Oil & Gas Sensors Market, By Connectivity*
    8.1 Introduction
    8.2 Wired
    8.2.1 North America is Expected to Be the Fastest Growing Market
    8.3 Wireless
    8.3.1 Wireless is Expected to Be the Fastest Growing Segment

    *9 Oil & Gas Sensors, By Sector*
    9.1 Introduction
    9.2 Upstream
    9.3 Midstream
    9.4 Downstream

    *10 Oil & Gas Sensors Market, By Region*
    10.1 Introduction
    10.2 North America
    10.2.1 By Sector
    10.2.2 By Type
    10.2.3 By Connectivity
    10.2.4 By Application
    10.2.5 By Country
    10.2.5.1 US
    10.2.5.2 Canada
    10.2.5.3 Mexico
    10.3 Asia Pacific
    10.3.1 By Sector
    10.3.2 By Application
    10.3.3 By Type
    10.3.4 By Connectivity
    10.3.5 By Country
    10.3.5.1 China
    10.3.5.2 Japan
    10.3.5.3 India
    10.3.5.4 Australia
    10.3.5.5 Rest of Asia Pacific
    10.4 Europe
    10.4.1 By Sector
    10.4.2 By Type
    10.4.3 By Connectivity
    10.4.4 By Application
    10.4.5 By Country
    10.4.5.1 Russia
    10.4.5.2 Norway
    10.4.5.3 Germany
    10.4.5.4 UK
    10.4.5.5 Italy
    10.4.5.6 Rest of Europe
    10.5 Middle East & Africa
    10.5.1 By Sector
    10.5.2 By Type
    10.5.3 By Connectivity
    10.5.4 By Application
    10.5.5 By Country
    10.5.5.1 Saudi Arabia
    10.5.5.2 Iran
    10.5.5.3 Algeria
    10.5.5.4 Kuwait
    10.5.5.5 Rest of Middle East & Africa
    10.6 South America
    10.6.1 By Sector
    10.6.2 By Application
    10.6.3 By Type
    10.6.4 By Connectivity
    10.6.5 By Country
    10.6.5.1 Brazil
    10.6.5.2 Argentina
    10.6.5.3 Venezuela
    10.6.5.4 Rest of South America

    *11 Competitive Landscape*
    11.1 Introduction
    11.2 Market Share Analysis
    11.3 Competitive Scenario
    11.3.1 New Product Launches
    11.3.2 Mergers and Acquisitions
    11.3.3 Expansions and Investments

    *12 Company Profiles*
    12.1 Benchmarking

    *13 Company Profiles*· ABB Ltd
    · BD Sensors
    · Bosch
    · Emerson
    · Fortive
    · General Electric (GE)
    · Honeywell
    · Indutrade
    · Lord
    · MTS Sensor Technologies GmbH
    · Rockwell
    · Siemens
    · TE Connectivity

    For more information about this report visit https://www.researchandmarkets.com/research/f7qqv9/9_4_billion_oil?w=12

    Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

    CONTACT:
    CONTACT: ResearchAndMarkets.com
    Laura Wood, Senior Press Manager
    press@researchandmarkets.com
    For E.S.T Office Hours Call 1-917-300-0470
    For U.S./CAN Toll Free Call 1-800-526-8630
    For GMT Office Hours Call +353-1-416-8900
    Related Topics: Oil, Gas and Chemical Sensors Reported by GlobeNewswire 3 hours ago.

    0 0

    [Guyana], Nov 16 (ANI): After a controlled performance to clinch the last four berth on a slow track, the Indian women's team will be considering their final group showdown against Australia on Reported by Sify 3 hours ago.

    0 0

    Eyeing a maiden Test series win Down Under, the Indian cricket team left for Australia Friday for a gruelling tour, which will see them play four matches in whites, three ODIs and as many T20 Internationals. Reported by Rediff.com 3 hours ago.

    0 0

    NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, HONG KONG, SOUTH AFRICA, SINGAPORE OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.

    AS Tallink Grupp (the “*Company*”) announces that it has received an exemption from the Finnish Financial Supervisory Authority (in Finnish: Finanssivalvonta) (the “*FIN-FSA*”) from the obligation to publish a prospectus in connection with the contemplated secondary listing of the Company's shares on the main list of Nasdaq Helsinki Ltd (“*Nasdaq* *Helsinki*”) in the form of Finnish share depositary receipts (the “*FDRs*”).

    As a condition for receiving the exemption from the obligation to publish a prospectus, the Company has prepared a listing summary (the “*Listing Summary*”) in Finnish and translated it into English.

    Both language versions of the Listing Summary are expected to be available in electronic form on the Company’s website at www.tallink.com/nasdaq-helsinki, and in Finnish on OP Financial Group’s website at www.op.fi/listautuminen, on or about 19 November 2018. Printed copies of both language versions of this Listing Summary are expected to be available at the Company’s headquarters at Sadama 5/7, 10111 Tallinn, Estonia, and printed copies of the Finnish language version are expected to be available at the service point of Nasdaq Helsinki at Fabianinkatu 14, FI-00100 Helsinki, Finland, on or about 19 November 2018.

    In addition, the Company announces that the Company has received acceptance forms from in total of 271 employees of Tallink Silja Oy and Tallink Silja AB to participate in the FDR reward program for the selected group of employees of Tallink Silja Oy and Tallink Silja AB announced with the stock exchange release dated 1 November 2018 (“*FDR program*”). As a result, the Company will allocate in total up to 203 250 FDRs to these employees pursuant to the FDR reward program.

    Veiko Haavapuu
    Financial Director

    AS Tallink Grupp
    Sadama 5/7
    10111 Tallinn, Estonia
    Tel. +372 640 9914
    E-mail veiko.haavapuu@tallink.ee

    *DISCLAIMER*

    None of the information contained herein constitute an offer to sell, or the solicitation of an offer to buy or acquire, any shares, FDRs, rights or other securities of AS Tallink Grupp in any jurisdiction whatsoever, including but not limited to, Finland, Estonia, and other member states of the European Economic Area. The information contained herein has been furnished solely for the purpose of communicating about the potential listing of, and commencement of trading in, the Company’s shares in the form of FDRs at the main list of Nasdaq Helsinki.

    The information contained herein is not an offer for sale of securities in the United States. The shares, FDRs, rights or other securities of the Company referred to on this website have not been and will not be registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration thereunder.

    The information contained herein is not intended for, and must not be accessed by, or distributed or disseminated to, persons resident or physically present in the United States, Australia, Canada, Hong Kong, Japan, New Zealand, South Africa or Singapore, and do not constitute an offer to sell or the solicitation of an offer to buy or acquire, any shares, FDRs, rights or other securities of the Company in the United States, Australia, Canada, Hong Kong, Japan, New Zealand, South Africa, Singapore or any other country in which it would be contrary to the laws and regulations of that country.

    None of the information contained herein constitute an offer of securities in the United Kingdom. No prospectus has been or will be approved in the United Kingdom in respect of the securities referred to herein. This information is only being distributed to and is only directed at (i) persons who are outside the United Kingdom or (ii) to investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”) or (iii) high net worth companies, and other persons to whom it may lawfully be communicated, falling within Article 49(2) of the Order (all such persons together being referred to as “relevant persons”). Any investment activity to which this document relates will be only available to, and will be engaged in only with, relevant persons. Any person who is not a relevant person should not act or rely on this document or any of its contents.

    This release includes forward-looking statements within the meaning of the securities laws of certain applicable jurisdictions. These forward-looking statements include, but are not limited to, all statements other than statements of historical facts contained in this release. By their nature, forward looking statements involve known and unknown risks, uncertainties and other factors because they relate to events and depend on circumstances that may or may not occur in the future. Tallink cautions readers that forward-looking statements are not guarantees of future performance and are based on numerous assumptions and that its actual results of operations, including their financial condition and liquidity and the development of the industries in which it and the members of its group operate, may differ materially from (and be more negative than) those made in, or suggested by, the forward-looking statements contained in this release. Reported by GlobeNewswire 3 hours ago.

    0 0

    *Kellyanne Conway*'s husband just took his criticisms of her boss up another notch...or five. Reported by Mediaite 2 hours ago.

    0 0

    Reported by SeekingAlpha 3 hours ago.

    0 0

    India's annual subsidies to sugarcane producers have breached the allowed limits by as much as tenfold in the past six years, Australia told the World Trade Organization in a document published by the world body on Friday. Reported by Reuters India 2 hours ago.

    0 0

    Dublin, Nov. 16, 2018 (GLOBE NEWSWIRE) -- The "Asia Pacific Biopharma Excipients Market Size, Share & Trends Analysis Report By Product (Polyols, Solubilizers & Surfactants/Emulsifiers, Carbohydrates, Specialty Excipients) And Segment Forecasts, 2018 - 2025" report has been added to *ResearchAndMarkets.com's* offering.

    The Asia Pacific biopharma excipients market size is poised to reach USD 791.4 million by 2025, exhibiting a CAGR of 6.63% during the forecast period.

    Patent expiry of blockbuster biologics such as Erbitux, Rituxan, Herceptin, Avastin, Aranesp, and Enbrel by 2030 is encouraging investments in biosimilars R&D by biopharma players. Soaring need for novel additives for development of biologics such as those enhancing lyophilization performance to improve stability of biologics is anticipated to boost the demand for excipients.

    As per drug sales record of 2016, eight out of ten top-selling drugs are biologics. Upcoming patent expiry of biologics is leading to increased R&D for biosimilar formulations. Biopharma players in the market are adopting price reduction strategies in order to promote their products. This is triggering the need for consideration of pricing strategy among excipient manufacturers.

    Presence of challenges in development of a stable form of biotherapeutic is urging manufacturers to develop novel excipients. Processing and storage of biomolecules are complicated as these products undergo degradation after a slight change in environmental conditions. Rising demand for chemicals that are compatible with these biomolecules and serve additional functions such as binding, bulking, and efficient delivery is stimulating the growth of the market.

    Technological advancements, such as implementation of nanotechnology in the development of novel compounds to enhance drug delivery, are likely to drive the market. For instance, an Australian provider of microencapsulation for drug delivery, Ceramisphere, expanded its operations for production of nanoparticles with extended-release capacity.

    Furthermore, Asian countries such as India & China serve as major markets for biogenerics. Key pharmaceutical players in the market are increasing their R&D activities on follow-on-biologic. Biologics R&D is outsourced to CROs in the region as a consequence of cost efficiency provided by them, which is consequently boosting the demand for excipients.

    *Further key findings from the report suggest:*

    · Carbohydrates accounted the largest revenue share due to substantial product penetration in the market owing to higher availability of raw materials as well as easy molecular processing characteristics
    · In terms of revenue, the polyols segment is projected to expand at a CAGR of 6.90% during the forecast period
    · Japan dominated the market in terms of revenue. However, in terms of sale volume, the Japanese economy was not on the top as a consequence of high product pricing
    · In February 2014, International Pharmaceutical Excipients Council of India (IPEC) was launched. Leading international pharmaceutical companies are founder members of this council, which includes Dow Chemicals, Lubrizol, BASF, SPI Pharma, Colorcon, Indchem International. It is estimated to assist the government of India in evolving direction, standards, and development of the excipient industry in the country, thus working in favor of the market
    · In August 2016, China FDA announced to review excipients as a part of new drug application. The former system considered separate review approvals for a drug, its excipient, and its active ingredient.
    · Some key companies present in the market are Roquette, DFE Pharma, Pharmonix, Spectrum Chemical Manufacturing Corp., IMCD, Clariant, Signet Chemical Corporation Pvt. Ltd., Sigachi Industries Pvt. Ltd., ABITEC, Colorcon, Meggle AG, SPI Pharma, and BASF SE. *
    *

    *Key Topics Covered:*

    *Chapter 1 Executive Summary*

    *Chapter 2 Research Methodology*

    *Chapter 3 Asia Pacific Biopharma Excipients Market Variables, Trends& Scope*
    3.1 Market Segmentation & Scope
    3.1.1 Market driver analysis
    3.1.1.1 Need for novel excipients in biologics/biosimilars development
    3.1.1.2 Increasing focus of pharma players on biogeneric market
    3.1.1.3 Cost-efficiency and competency of manufacturers
    3.1.1.4 Patent expiry of biological actives
    3.1.2 Market restraint analysis
    3.1.2.1 Challenges in development of excipients for biologics
    3.1.2.2 Problems in supply chain
    3.1.2.3 Patent challenges and disputes over biosimilars
    3.2 Penetration & Growth Prospect Mapping for Products, 2017
    3.3 Biopharma Excipients Market-SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
    3.4 Industry Analysis - Porter's

    *Chapter 4 Asia Pacific Biopharma Excipients Market Categorization: Product Estimates & Trend Analysis*
    4.1 Asia Pacific Biopharma Excipients Market: Product Movement Analysis
    4.2 Solubilizers & Surfactants/Emulsifiers
    4.2.1 Asia Pacific solubilizers & surfactants/emulsifiers market, by revenue 2014 - 2025 (USD Million)
    4.2.2 Asia Pacific solubilizers & surfactants/emulsifiers market, by volume 2014 - 2025 (Tons)
    4.2.3 Triglycerides
    4.2.4 Esters
    4.2.5 Other solubilizer
    4.3 Polyols
    4.3.1 Asia Pacific polyols market, by revenue 2014 - 2025 (USD Million)
    4.3.2 Asia Pacific polyols market, by volume 2014 - 2025 (Tons)
    4.3.3 Mannitol
    4.3.4 Sorbitol
    4.3.5 Other polyols
    4.4 Carbohydrates
    4.4.1 Asia Pacific carbohydrates market, by revenue 2014 - 2025 (USD Million)
    4.4.2 Asia Pacific carbohydrates market, by volume 2014 - 2025 (Tons)
    4.4.3 Dextrose
    4.4.4 Sucrose
    4.4.5 Starch
    4.4.6 Others
    4.5 Specialty Biopharma Excipients/Others

    *Chapter 5 Asia Pacific Biopharma Excipients Market Categorization: Regional Estimates & Trend Analysis*
    5.1 Asia Pacific Biopharma Excipients Market: Regional Movement Analysis
    5.2 Japan
    5.3 China
    5.4 India
    5.5 Malaysia
    5.6 South Korea
    5.7 Philippines
    5.8 New Zealand
    5.9 Australia
    5.10 Singapore
    5.11 Indonesia

    *Chapter 6 Competitive Landscape*
    6.1 Strategy Framework
    6.2 Market Participation Categorization
    6.3 Company Profiles· Merck KGaA
    · Signet Chemical Corporation Pvt. Ltd.
    · Sigachi Industries Pvt. Ltd.
    · ABITEC
    · Spectrum Chemical Manufacturing Corp.
    · Roquette
    · IMCD
    · Pharmonix
    · Clariant
    · DFE Pharma
    · Colorcon
    · SPI Pharma
    · JRS PHARMA
    · BASF SE

    For more information about this report visit https://www.researchandmarkets.com/research/dkl97g/asia_pacific?w=12
    Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

    CONTACT:
    CONTACT: ResearchAndMarkets.com
    Laura Wood, Senior Press Manager
    press@researchandmarkets.com
    For E.S.T Office Hours Call 1-917-300-0470
    For U.S./CAN Toll Free Call 1-800-526-8630
    For GMT Office Hours Call +353-1-416-8900
    Related Topics: Biopharmaceuticals , Pharmaceutical Intermediates Reported by GlobeNewswire 3 hours ago.

    0 0

    Poverty causing 'misery' in UK, and ministers are in denial, says UN official A UN expert from Australia says he encountered "misery" as he spent 12 days touring the UK. Reported by BBC News 2 hours ago.

    0 0

    Pharmacist accused of strangling wife ‘was fantasist who lied couple were parents of twins’  Mitesh Patel, 37 and from Middlesbrough, was obsessed by the idea of having a baby with wife Jessica, 34, it is alleged. But only so he could take the child to live with his male lover in Australia. Reported by MailOnline 2 hours ago.

    0 0

    Dublin, Nov. 16, 2018 (GLOBE NEWSWIRE) -- The "Gene Expression Analysis Market by Product and Services (Consumables (Reagents, DNA chips), Instruments (PCR, NGS), Services (Gene Expression Profiling)), End User (Pharma and Biotech Companies, Research Centers) - Global Forecasts to 2023" report has been added to *ResearchAndMarkets.com's* offering.The market for gene expression analysis market is expected to grow from USD 3.2 billion in 2018 to USD 4.9 billion by 2023, at a Compound Annual Growth Rate (CAGR) of 8.8% during the forecast period.

    Growth in the market is primarily driven by factors such as the rising prevalence of cancer, growing application areas of genomics, and the availability of gene expression databases.

    *By product and services, the consumables segment is expected to grow at the highest rate during the forecast period*

    The increasing volume of genetic tests in drug discovery, biomarker discovery, and pharmacogenomics applications are driving the growth of the consumables market. The increasing installation of NGS and PCR equipment worldwide will significantly boost the demand for consumables.

    *By end user, pharmaceutical and biotechnology companies are expected to be the largest contributor to the gene expression analysis market*

    Pharmaceutical and biotechnology companies utilize gene expression analysis products and services to achieve their clinical research goals, such as drug discovery and development and biotech research. Biopharmaceutical companies focus on developing targeted therapies, especially for the treatment of cancer, complex diseases, and rare genetic disorders. CROs offer a number of gene expression analysis services, including gene expression profiling services such as NGS. This is increasing the demand for gene expression analysis services offered by CROs.

    *North America is expected to hold a significant share in the gene expression analysis market during the forecast period*

    Factors such as the development of gene therapy, focus on gene expression studies, government initiatives, and the availability of funding for NGS research are driving the growth of the market in North America.

    The major vendors in the global market are Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), and Bio-Rad Laboratories, Inc. (US). Other players involved in this market are F. Hoffmann-La Roche Ltd. (Switzerland), GE Healthcare (UK), Pacific Biosciences of California, Inc. (US), BGI (China), PerkinElmer (US), Agilent Technologies Inc. (US), QIAGEN N. V. (Netherlands), Oxford Gene Technologies, Ltd. (UK), and Eurofins Scientific (Luxembourg).

    *Market Developments*

    · Biorad acquired of RainDance Technologies, a droplet-based PCR systems manufacturer. RainDance Technologies has a more focused portfolio, primarily known for its droplet-based technologies for digital PCR (dPCR).
    · Thermo Fisher Scientific completes acquisition of Affymetrix, a leading provider of cellular and genetic analysis products.

    *Key Topics Covered**1 Introduction*
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
    1.3.1 Markets Covered
    1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

    *2 Research Methodology*
    2.1 Research Methodology Steps
    2.1.1 Secondary and Primary Research Methodology
    2.1.2 Secondary Research
    2.1.2.1 Secondary Sources
    2.1.2.2 Primary Research
    2.1.2.3 Primary Sources
    2.1.2.4 Key Insights From Primary Sources
    2.1.3 Market Size Estimation Methodology
    2.1.4 Market Data Estimation and Triangulation
    2.2 Assumptions

    *3 Executive Summary*

    *4 Premium Insights*
    4.1 Gene Expression Analysis Market Overview
    4.2 Geographic Analysis: European Market, By Product & Services
    4.3 Market, By Product and Services, 2018 vs 2023
    4.4 Market, By End User, 2018 vs 2023
    4.5 Geographic Snapshot of the Gene Expression Analysis Market

    *5 Market Overview*
    5.1 Introduction
    5.2 Market Dynamics
    5.2.1 Drivers
    5.2.1.1 Decreasing Cost of Sequencing
    5.2.1.2 Technological Advancements
    5.2.1.3 Rising Prevalence of Cancer
    5.2.1.4 Availability of Government Funding
    5.2.1.5 Novel Technologies to Aid Gene Expression Studies
    5.2.1.6 Growing Application Areas of Gene Expression
    5.2.1.7 Availability of Gene Expression Databases
    5.2.2 Restraints
    5.2.2.1 High Cost of Instruments
    5.2.2.2 Shortage of Trained Professionals
    5.2.3 Opportunities
    5.2.3.1 Emerging Countries to Provide Growth Opportunities
    5.2.3.2 Growing Use of Gene Expression Analysis in Precision Medicine
    5.2.4 Challenges
    5.2.4.1 Currency Devaluation

    *6 Market, By Product & Service*
    6.1 Introduction
    6.2 Consumables
    6.2.1 The Market for Consumables is Estimated to Account for A Share of 62.0% of the Total Market in 2018. the Consumables Segment is Further Divided Into Reagents and Microarray/DNA Chips.
    6.3 Reagents
    6.3.1 Growing Number of Sequencing Service Centers to Aid the Growth of the Reagents Market
    6.4 DNA Chips
    6.4.1 Declining Use of DNA Microarray Technology Expected to Result in Sluggish Growth
    6.5 Instruments
    6.6 PCR Instruments
    6.6.1 Advent of Enhanced Ddpcr to Aid the PCR Market for Gene Expression
    6.7 Next-Generation Sequencing Instruments
    6.7.1 NGS to Overtake Microarrays Market in the Coming Years
    6.8 DNA Microarrays
    6.8.1 Despite Sluggish Growth Rate, DNA Microarrays Will Witness Sustained Use in the Coming Years
    6.9 Other Instruments
    6.9.1 Growing Focus on Cancer Therapeutics, Genetics Will Support the Market for Sage
    6.10 Services
    6.11 Gene Expression Profiling Services
    6.12 Sequencing Services
    6.12.1 Reduction in Sequencing Costs, Technological Advancements Will Drive the Market for Sequencing Services
    6.13 Other Services
    6.13.1 Wide Application Areas of QPCR Services to Aid in the Growth of This Market Segment
    6.13.2 Bioinformatics Solutions

    *7 Market, By End User*
    7.1 Introduction
    7.2 Pharmaceutical and Biotechnology Companies
    7.2.1 Increasing Clinical Research on Drug Discovery and Biomarker Development to Support the Growth of This End-User Segment
    7.3 Academic Institutes and Research Centers
    7.3.1 Growing Government Funding to Drive the Adoption of Gene Expression Analysis Techniques in Academic Institutes and Research Centers
    7.4 Other End Users
    7.4.1 This Segment Includes Non-Profit Organizations (NPOS), Agri-Genomics Organizations, Reference Laboratories, and Consumer Genomics Companies

    *8 Market, By Region*
    8.1 Introduction
    8.2 North America
    8.2.1 US
    8.2.2 Canada
    8.3 Europe
    8.3.1 UK
    8.3.2 Germany
    8.3.3 Spain
    8.3.4 France
    8.3.5 Italy
    8.3.5.1 Government Funding for Life Science Research to Aid the Italian Market
    8.3.6 Rest of Europe
    8.4 Asia Pacific
    8.4.1 China
    8.4.1.1 Domestic Manufacturing of Sequencing Systems to Drive Market Growth in China
    8.4.2 Japan
    8.4.2.1 Increasing Government Focus on Cancer Research to Drive the Market Growth in Japan
    8.4.3 Australia
    8.4.3.1 Increasing Research Activities in the Fields of Genetics and Genomics to Aid Market Growth in Australia
    8.4.4 India
    8.4.4.1 Decreasing Sequencing Cost and Growing Prevalence of Target Diseases to Support Market Growth in India
    8.4.5 Rest of Asia Pacific (RoAPAC)
    8.5 Rest of the World (RoW)
    8.5.1 Greater Adoption of Genetic Testing and Genomic Analysis to Drive Market Growth in This Region

    *9 Competitive Landscape*
    9.1 Overview
    9.2 Market Ranking of Players, 2017
    9.3 Competitive Scenario
    9.3.1 Product Launches & Approvals
    9.3.2 Acquisitions
    9.3.3 Partnerships, Agreements, & Collaborations

    *10 Company Profiles*
    10.1 Thermo Fisher Scientific, Inc.
    10.1.1 Business Overview
    10.1.2 Products Offered
    10.1.3 Recent Developments
    10.2 Bio-Rad Laboratories, Inc.
    10.3 Illumina, Inc.
    10.4 Agilent Technologies
    10.5 F. Hoffmann-La Roche
    10.6 GE Healthcare
    10.7 Perkinelmer, Inc.
    10.8 Qiagen N.V.
    10.9 Oxford Gene Technology
    10.10 Pacific Biosciences of California, Inc.
    10.11 BGI
    10.12 Eurofins ScientificFor more information about this report visit https://www.researchandmarkets.com/research/6tgkgt/gene_expression?w=12

    CONTACT:
    CONTACT: ResearchAndMarkets.com
    Laura Wood, Senior Press Manager
    press@researchandmarkets.com
    For E.S.T Office Hours Call 1-917-300-0470
    For U.S./CAN Toll Free Call 1-800-526-8630
    For GMT Office Hours Call +353-1-416-8900
    Related Topics: Genomics Reported by GlobeNewswire 2 hours ago.

    0 0

    Riga, Latvia, 16 November 2018. Mogo Finance and its group companies (the “Group”), specialized in used car financing, announce the settlement and listing of the EUR 25 million tap on its existing 9.50% corporate bond 2018/2022 (XS1831877755) effective today in the Open Market of the Frankfurt Stock Exchange. The announced listing of the bonds on the regulated market of the Frankfurt Stock Exchange will follow soon, subject to the expected approval of the prospectus by the CSSF in Luxembourg.

     

    For more information, please contact:

    Mogo Finance (CFO)  Email: maris.kreics@mogofinance.com

    Maris Kreics  +371 66 900 900

     

    Aalto Capital  Email: sven.pauly@aaltocapital.com

    Sven Pauly  +49 89 898 67 77 0

     

    *Notes to Editors:*

    Mogo Finance is one of largest and fastest growing secured used car financing companies in Europe. Recognizing the niche in used car financing underserved by traditional lenders, Mogo Finance has expanded its operations to 12 countries issuing over EUR 320 million up to date and running a net loan portfolio over EUR 130 million. Mogo offers secured loans up to EUR 15,000 with maximum tenor of 84 months making used car financing process convenient, both for its customers and partners. Wide geographical presence makes Mogo unique over its rivals and diversifies revenue streams.

    Mogo Finance operates through its own branch network, more than 1,500 partner locations and strong online presence. Physical footprint makes Mogo Finance top of mind brand in used car financing. Established in 2012, headquartered in Riga, Latvia and operates in: Latvia, Estonia, Lithuania, Georgia, Poland, Romania, Bulgaria, Moldova, Albania, Belarus, Armenia and Ukraine.

    www.mogofinance.com

    *IMPORTANT INFORMATION*

    The information contained herein is not for release, publication or distribution, in whole or in part, directly or indirectly, in or into the United States, Australia, Canada, Hong Kong, Japan, New Zealand, South Africa or any other countries or otherwise in such circumstances in which the release, publication or distribution would be unlawful. The information contained herein does not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, the bonds in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration, exemption from registration or qualification under the securities laws of any such jurisdiction. Persons into whose possession this announcement may come are required to inform themselves of and observe all such restrictions. None of Mogo Finance, KNG Securities LLP, ABG Sundal Collier AB, Bankhaus Scheich Wertpapierspezialist AG, BlueOrange Bank AS, Gottex Brokers SA and STX Fixed Income B.V. or their respective representatives accept any legal responsibility for any violation by any person, whether or not the persons contemplating investing in or divesting Mogo’s securities, including the bonds, are aware of such restrictions.

    This announcement does not constitute an offer of securities for sale in the United States. The bonds have not been and will not be registered under the Securities Act or under the applicable securities laws of any state of the United States and may not be offered or sold, directly or indirectly, within the United States or to, or for the account or benefit of, U.S. persons except pursuant to an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act.

    This announcement constitutes advertising material and is meant as preliminary information about an upcoming securities offering by the Issuer for sounding general investor interest. This document in particular does not constitute a prospectus for the purposes of Directive 2003/71/EC, as amended (the “*Prospectus Directive*”) and does not constitute a public offer of securities in any member state of the European Economic Area (the “*EEA*”).

    This announcement does not constitute an offer of bonds to the public in the United Kingdom. No prospectus has been or will be approved in the United Kingdom in respect of the bonds. Accordingly, this announcement is not being distributed to, and must not be passed on to, the general public in the United Kingdom. The communication of this announcement as a financial promotion may only be distributed to and is only directed at (i) persons who are outside the United Kingdom or (ii) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”) or (iii) high net worth companies, and other persons to whom it may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons in (i), (ii) and (iii) above together being referred to as “Relevant Persons”). Any invitation, offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in only with, Relevant Persons. Any person who is not a Relevant Person should not act or rely on this announcement or any of its contents.

    PROFESSIONAL INVESTORS ONLY – Manufacturer target market (MIFID II product governance) is eligible counterparties and professional clients only (all distribution channels). No PRIIPs key information document (KID) has been prepared as the bonds do not constitute packaged products and will be offered to eligible counterparties and professional clients only.

     

      Reported by GlobeNewswire 2 hours ago.

    0 0

    Justin Trudeau in Papua New Guinea to discuss trade with Asian leaders High Minister Justin Trudeau walks into this weekend’s APEC leaders’ summit with a possibility to easy over lingering sore emotions with a few of Canada’s key buying and selling companions at the Pacific Rim. Trudeau will meet his opposite numbers from Australia and Japan, and be able to stumble upon leaders from the 21 international … Reported by The News Articles 2 hours ago.

    0 0

    SUZHOU, China, Nov. 17, 2018 /PRNewswire/ -- Alphamab Oncology announced the successful completion of series A financing round, with more than $100 million raised. A number of well-regarded institutional investors, including Advantech Capital, PAG, China Venture Capital Fund^[1], OrbiMed, Heritage Provider Network and Janchor Partners, participated in the financing.

    Alphamab Oncology plans to use the proceeds to advance global clinical development of its innovative pipeline, especially its second-generation immuno-oncology medicine, to expand its global clinical and commercial teams, as well as to complete the ongoing construction of its state-of-the-art biologics manufacturing facilities.

    Alphamab Oncology inherited Suzhou Alphamab's oncology pipeline and related technology platforms. The company focuses on the research and development of innovative biologics for cancer therapy, and it has developed several proprietary and robust technology platforms for bispecific and mixed antibodies. Leveraging on these world-leading protein engineering platforms, Alphamab Oncology is well positioned to develop next-generation multi-functional biologics therapy for cancer treatment.

    So far, four drug candidates in Alphamab Oncology's pipeline have advanced into clinical development phase:

    · KN035 (Envafolimab), the world's leading subcutaneously-administered PD-L1antibody, has entered pivotal trials in China and is expanding its indications. KN035 was discovered and developed internally. It is in partnership with 3D Medicines on the clinical development
    · KN046, the world's first PD-L1 - CTLA-4 bispecific antibody, was also solely developed internally. It is in phase I clinical trial in Australia, and will soon kick off multiple phase I/II clinical trials in China, with BLA enabling trials planned as well.
    · KN026, the anti-HER2 bispecific antibody, has entered phase I clinical trial in China. With the recent US IND approval, its US phase I trial will be initiated in the near future.
    · Phase I clinical trials of the immunomodulator KN019 in China are being wrapped up, and phase II clinical trial is expected in H1, 2019.

    ^[1] China Venture Capital Fund is completing the closing process.

    Dr. Xu Ting, Chairman and CEO of Alphamab Oncology, said: "We are honored to be recognized and supported by these well-regarded investors. We expect to work with them to expedite the progress in global clinical trial and commercialization of our highly differentiated and innovative products, to further strengthen our presence and unique advantages in the fast-growing global immuno-oncology drug market, and to bring much needed innovative therapies to global cancer patients sooner than later. Meanwhile, we are looking for collaboration opportunities to expand our footage in oncology area."

    Advantech Capital's Co-Head of Healthcare Investment, Mr. Qiu Yumin commented, "Alphamab Oncology team, under the leadership of Dr. Xu Ting, has been leading the biologics drug innovation in China, in terms of R&D capability and track record. Alphamab is also at the forefront of developing globally competitive biologics platforms, such as its bispecific antibody platform and domain antibody platform. With the construction of new manufacturing site on track, Alphamab Oncology has presented huge potential to develop into a fully integrated bio-pharmaceutical company across the entire value chain."

    He added, "Healthcare is one of the two investment focuses at Advantech. As a leading player in developing next-generation biotherapeutics, Alphamab Oncology fits well with Advantech's philosophy of investing in high-tech and high growth potential targets. Advantech will support the company in building a world-class immuno-oncology company."

    Dr. Dong Lyu, Executive Director of PAG said: "The company team led by Dr. Xu Ting has accumulated a wealth of R&D experience in the field of antibody drugs, both in novel single-domain antibodies and in bispecific antibody drugs. The company has formed a robust pipeline of antibody drugs built on its proprietary platforms, which are all industry-leading. Alphamab Oncology currently has several products in different stages of clinical research in China, the United States, Japan and Australia, with the most advanced product in its pipeline, KN035, expected to obtain market approval within a relatively short period of time with a distinct clinical advantage. In addition, Alphamab Oncology has started constructing a commercial manufacturing site, with a number of cGMP production lines meeting NMPA, EMA and FDA requirements, allowing Alphamab Oncology to cover the entire product development life cycle from early screening and engineering of antibody/protein drugs, cell line construction and small batch tests, pilot scale amplification and preparation of clinical research samples, to mass production of commercialized products."

    Dr. Dong Lyu continued, "PAG has a long track record of investing in the healthcare sector, and a comprehensive and in-depth understanding of innovative drugs, especially in the field of biologics. We see Alphamab Oncology as a leader in the area of innovative biological drugs, and have full confidence in the future of the company. PAG is committed to working with Alphamab Oncology to build a global leader in the development and production of biological drugs for oncology and immunotherapy."

    Mr. Shaojing Ma, Managing Director of China Venture Capital Fund (CVC) commented, "China innovative drug industry is embracing superior development opportunities, within which the innovative oncology biologics sector has become a focus with tremendous market potential. With world-class R&D capability, Alphamab Oncology has the potential to become a leader of China biopharmaceutical industry. Dr. Ting Xu is a preeminent entrepreneur, and he has deep understanding of the market and technology. The investment will strongly promote the industrialization of innovative biotech in China, fitting well with the investment strategy of CVC.

    Ms. Iris Wang, director of OrbiMed Asia Pacific, commented, "Chinese biotech industry is becoming an increasingly important and notable contributor to global research and development of innovative medicine. We are very pleased to have the opportunity to support Alphamab Oncology to address significant unmet medical needs worldwide and we have great confidence in the execution capabilities of the management team."

    About Alphamab Oncology

    Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development, manufacturing and commercialization of world-class innovative therapeutics for cancer treatment. With multiple in-house proprietary platforms, including bispecifics, protein engineering and antibody screening, Alphamab Oncology has built a robust pipeline in oncology/immunology. We strive to develop next-generation or best-in-class medicines to address global unmet medical needs.

    Please feel free to visit the official website: http://www.alphamabonc.com

    About Advantech Capital:

    Advantech Capital is a private equity investment fund, focusing on innovation-driven growth opportunities in China, mainly investing in TMT, pharmaceuticals and healthcare.

    About PAG:

    PAG is a leading Asia-focused alternative investment firm with funds under management across private equity, real estate and absolute return strategies. PAG currently manages more than US$20 billion in capital for some of the world's largest private and institutional investors. PAG's investment in Alphamab comes from its Growth Capital strategy, which focuses on growth equity investments in "New Economy" sectors, with healthcare a core sector.

    About China Venture Capital Fund (CVC):

    CVC is a 200 billion yuan venture capital fund established in 2016, after approval by China's State Council and China SASAC. The main objective of CVC is to invest in innovative technology and industrial upgrading projects. The field of biotech & healthcare is one of focused areas of CVC.

    About OrbiMed:

    OrbiMed is a leading investment firm dedicated exclusively to the healthcare sector, with over $14 billion in assets under management. OrbiMed invests globally across the spectrum of healthcare companies, from venture capital start-ups to large multinational corporations, utilizing a range of private equity funds, public equity funds, royalty/credit funds and other investment vehicles. OrbiMed maintains its headquarters in New York City, with additional offices in San Francisco, Shanghai, Mumbai, Herzliya and Hong Kong. OrbiMed seeks to be a capital provider of choice, with the flexibility to provide equity and debt capital solutions that are tailored to the unique needs of our portfolio companies. The firm's global team of over 80 professionals brings the resources and experience required to be an exceptional long-term partner in building world-class healthcare companies.

    About Heritage Provider Network:

    Established in 1979 by Dr. Richard Merkin, Heritage Provider Network is the largest physician - owned integrated healthcare services delivery network in the US with approximately 1 million patient - members.

    About Janchor Partners:

    Established in 2009, Janchor Partners is a long-term industrialist investor, partnering with companies that have superior business models, favorable growth prospects and the potential to be part of long-term positive structural dynamics of Asian countries and economies. As a genuine thought partner with its investee companies, Janchor Partners helps to increase long-term corporate value and builds strong and meaningful long-term relationships with investee companies.

    Related Links :

    http://www.alphamabonc.com Reported by PR Newswire Asia 2 hours ago.

    0 0

    Veteran L Sarita Devi and rookie Manisha Mouna gave India a flying start in the women's World Boxing Championship with dominating victories in their respective bouts on Friday.

    While Manisha punched above her weight to outclass veteran American Christina Cruz in a unanimous verdict in 554kg, 2006 edition gold medallist Sarita (60kg) had to work harder to emerge 4-0 winner on points against Diana Sandra Brugger of Switzerland in their opening bouts at the KD Jadhav Stadium in New Delhi.

    Both Sarita and Manisha advanced to the prequarterfinals where they will face Kellie Herrington of Ireland and Dina Zholaman of Kazakhstan respectively on Sunday. Harrington had won a silver in 64kg in the 2016 World Championships but she has gone one weight category down in this tournament. She beat Troy Garton of New Zealand on Friday.

    Zholaman is the defending world champion but Manisha has beaten her in the Silesian Women's Boxing championship in Poland earlier this year. The 20-year-old Manisha from Haryana, who was making her debut in the World Championships, was in complete control during the first round bout against the American who is almost twice her age.

    The 36-year-old Cruz from New York was the last edition's bronze medallist besides winning the same colour of medal in 2012 also. Manisha, who had won a gold in the India Open and a silver in the Poland event this year, was the clear winner as she dominated all the three rounds. The five judges gave her a unanimous decision (29-28, 30-27, 30-26, 30-26, 29-28).

    Manisha's mother Usha Rani and grandmother Saroj Devi, who had come all the way from Kaithal, were at the stands to watch her bout. "I am very proud for winning my first bout in the World Championships. I have proved that I can be at this stage. I will give my best and see how far I can go. I am confident of doing well in the coming rounds," she said. "My next bout is against the world champion but I have beaten her in Poland. It will be tough but I can beat her," she added.

    Asked about the strategy for the bout, she said everything went according to plan. "My coaches told me to play from a distance. Her (Cruz's) right was very strong so coaches told me to watch here right. I tried to miss her punches from the right and attacked from the left. That was the plan and I did just that," she said.

    "The first round was about observing my opponent and find out what to do and what not to do. In the second round, I went with the plan and I was able to land my punches. In the third round, I went for attack and gave the best attack and won the bout," she added.

    Zholaman, who beat Muzuki Hiruta of Japan 4-1, said Manisha is a "good" boxer. "I lost to her (Manisha) in Poland but that is boxing, it happens. She is a good boxer," said the Kazakh.

    The 36-year-old Sarita faced a tough fight from her experienced Swiss opponent, who also has been in the international circuit for more than a decade, before winning 4-0 (28-28, 29-28, 30-27, 29-28, 29-28). The Manipuri boxer, who has been competing in the World Championships since the first edition in 2001, was clearly the better boxer as all the five judges gave points in her favour.

    In the second round, the Swiss got a standing count after a hard punch from Sarita landed on her face. Still, one judge gave the Swiss 10-9. In the third round, Sarita showed signs of tiredness but she carried through the bout. Only one judge ruled in her favour in the third round while the other four awarded identical 10-9 in favour of the Swiss.

    After the bout, Sarita admitted that she was finding it difficult to control her opponent. "In the first round I was trying to observe her and find out how to go about in the next two rounds. But she came attacking from the first round itself. I was finding it difficult to control her," she said.

    "Under the new points system, you need to have a proper guard and combination of punches to fetch points. That was what I was doing. She got a standing count in the second round and in the third round I was trying to attack."

    Sarita dedicated the win to the people of Manipur who had contributed financially to pay the fine after she was banned for one year in 2014 following the Incheon Asian Games controversy in which she refused to accept the bronze medal at the victory ceremony.

    "The people of Manipur contributed money to pay my fine and so I dedicate this win to them." In other bouts of the day, 2016 World Championship and Rio Olympics bronze medallist Mira Potkonen of Finland beat Commonwealth Games gold winner Anja Stridsman of Australia in 60kg.

    Another Rio bronze winner in 60kg, Anastasia Beliakova of Russia moved to the pre-quarters with a unanimous verdict win over Elisa Williams of Panama. In 48kg, Algerim Kassenayeva of Kazakhstan beat Jazzelle Bobadilla of United States in a 3-2 split decision to earn the right to face five-time world champion M C Mary Kom on Sunday.

    Article Type: 
    Report
    Sections: 
    Sports
    Agencies: 
    PTI
    Tags: 
    Sarita Devi
    Boxing
    Boxer
    World Boxing Championship
    Manisha Mouna
    India
    Fri, 16 Nov 2018-10:00pm
    Date updated: 
    Friday, 16 November 2018 - 10:00pm
    Article Images: 
    PTI
    Short URL: 
    dnai.in/fLBc
    Embargo: 
    Syndicate: 
    Hide lead image: 
    Page views: 
    1
    From Print Edition: 
    Highlights:  Reported by DNA 57 minutes ago.

    0 0

    The Proteas are aiming to continue building a winning culture in the one-off T20 international against Australia. Reported by News24 1 hour ago.

    0 0

    The current Indian pace attack is being considered as the best India have ever had as a group and Gilchrist feels that they have shown tremendous potential. Reported by DNA 1 hour ago.

older | 1 | .... | 1400 | 1401 | (Page 1402) | 1403 | 1404 | .... | 1460 | newer